Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jean Maillefert
Determining a Low Disease Activity Threshold for Decision to Maintain Disease-Modifying Antirheumatic Drug Treatment Unchanged in Rheumatoid Arthritis Patients
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
Related publications
Lipid Profiles in Rheumatoid Arthritis Patients Treated With Disease-Modifying Antirheumatic Drugs
Reumatologia
Rheumatology
Allergy
Immunology
Predictors of Stopping and Starting Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis
Arthritis Care and Research
Rheumatology
FRI0754-HPR Impact of Corticosteroid Utilization on Biologic Disease-Modifying Antirheumatic Drug Initiation Among Patients With Rheumatoid Arthritis
High Incidence of Disease Recurrence After Discontinuation of Disease-Modifying Antirheumatic Drug Treatment in Patients With Psoriatic Arthritis in Remission
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Leflunomide in Disease Modifying Treatment of Rheumatoid Arthritis in Elderly Patients
Nauchno-Prakticheskaya Revmatologiya
Rheumatology
Allergy
Immunology
Cost-Effectiveness of a JAK1/JAK2 Inhibitor vs a Biologic Disease-Modifying Antirheumatic Drug (bDMARD) in a Treat-To-Target Strategy for Rheumatoid Arthritis
ClinicoEconomics and Outcomes Research
Health Policy
Economics
Econometrics
Finance
Association of Seropositivity and Mortality in Rheumatoid Arthritis and the Impact of Treatment With Disease‐Modifying Antirheumatic Drugs
Arthritis Care and Research
Rheumatology
Changes in Use of Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis in the United States During 1983-2009
Arthritis Care and Research
Rheumatology
Combined Disease Modifying Treatment of Rheumatoid Arthritis With Methotrexate and Hydroxychloroquine
Nauchno-Prakticheskaya Revmatologiya
Rheumatology
Allergy
Immunology
